Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Selenium therapy in colorectal tumors?].

K Lasch1, C Bräsel, H Jahn

  • 1Interdisziplinäres Therapiezentrum Weissenburg, Rehabilitationsklinik für Onkologie und Rheumatologie, Friedrich-Schiller-Universität Jena.

Medizinische Klinik (Munich, Germany : 1983)
|November 11, 1999
PubMed
Summary

Selenium supplementation may benefit colorectal cancer patients by improving selenium status and enhancing quality of life. Further research is needed to confirm these effects and understand the mechanisms involved.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease-authors' reply.

Alimentary pharmacology & therapeutics·2018
Same author

Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply.

Alimentary pharmacology & therapeutics·2017
Same author

Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2017
Same author

Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial.

Alimentary pharmacology & therapeutics·2016
Same author

New Observer-Reported Outcomes To Measure Treatment Satisfaction, Compliance, Palatability, and Gi Symptoms for Patients Needing Iron-Chelation Therapy.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Modification of Patient Reported Outcomes Measures of Compliance, Gastrointestinal Symptoms, Palatability and Treatment Satisfaction for Patients Needing Iron Chelation therapy.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016

Area of Science:

  • Oncology
  • Nutritional Biochemistry
  • Clinical Medicine

Background:

  • Investigating the role of selenium in colorectal cancer therapy.
  • Assessing selenium's impact on patient well-being.

Purpose of the Study:

  • To evaluate the efficacy of selenium supplementation in colorectal cancer patients.
  • To determine selenium's effect on tumor markers and quality of life.

Main Methods:

  • A 19-day selenium supplementation trial in 53 colorectal cancer patients.
  • Comparison with a control group (41 patients).
  • Measurement of serum selenium, blood selenium, GSH-Px activity, TBARS, and CA 19-9 tumor marker.

Main Results:

  • Observed latent selenium deficiency, with selenium status correlating to CA 19-9 levels.
  • Selenium supplementation improved selenium status and increased GSH-Px activity.
  • Patients reported improved quality of life and decreased physical complaints.

Conclusions:

  • Selenium supplementation shows potential benefits for colorectal cancer patients.
  • Further research is required to understand selenium's influence on tumor markers and cancer development.
  • Investigating selenium's role in immunomodulation and its effect on patient quality of life is warranted.

Related Experiment Videos